REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Filimed S.R.O. (Czech Republic)

Main Activities: Offices of Physicians | Offices of Dentists
Secondary Activities: Lessors of Other Real Estate Property
Full name: Filimed S.R.O. Profile Updated: December 07, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Filimed S.R.O. is based in Czech Republic, with the head office in Ricany. It operates in the Offices of Physicians industry. It was first established on November 14, 2018. Filimed S.R.O. currently employs 100 - 199 (2025) people. From the latest financial highlights, Filimed S.R.O. reported a net sales revenue increase of 15.39% in 2024. Over the same period, its total assets grew by 5.91%. The net profit margin of Filimed S.R.O. increased by 3.29% in 2024.

Headquarters
Nad Bahnivkou 231
Ricany; Stredocesky; Postal Code: 25101

Contact Details: Purchase the Filimed S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Filimed S.R.O. report to view the information.
Registered Capital:
Purchase the Filimed S.R.O. report to view the information.
Financial Auditors:
Purchase the Filimed S.R.O. report to view the information.
Incorporation Date:
November 14, 2018
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
30%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Filimed S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
15.39%▲
Total operating revenue
16.45%▲
Operating profit (EBIT)
105.47%▲
EBITDA
97.04%▲
Net Profit (Loss) for the Period
100.59%▲
Total Assets
5.91%▲
Total Equity
-15.94%▼
Operating Profit Margin (ROS)
4.42%▲
Net Profit Margin
3.29%▲
Return on Equity (ROE)
99.49%▲
Debt/Equity
-5.47%▼
Quick Ratio
-0.05%▼
Cash Ratio
-0.16%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo